SPPAM
HALO icon

Summit Partners Public Asset Management’s Halozyme HALO Stock Holding History

Summit Partners Public Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-349,900
Closed -$12.6M – 150
2023
Q2 		$12.6M Buy
+349,900
New +$11.9M 0.47% 71

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Summit Partners Public Asset Management's HALO Position: Q3 2023 in Review

Summit Partners Public Asset Management sold out of Halozyme (HALO) in Q3 2023, closing a stake of 368,584 shares — an estimated $13.3M sold.

Summit Partners Public Asset Management first reported a position in HALO in Q2 2023 and held it in 1 quarter. The position peaked at $13.3M in Q2 2023. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

  • Summit Partners Public Asset Management reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 368,584 Halozyme shares in Q3 2023, an estimated $13.3M.
  • Summit Partners Public Asset Management first reported a position in Halozyme in Q2 2023 and held it in 1 quarter.
  • Summit Partners Public Asset Management's Halozyme position peaked at $13.3M in Q2 2023.
  • 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on Summit Partners Public Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.